“Global Intraosseous Infusion Devices Market to reach a market value of USD 1.4 Billion by 2031 growing at a CAGR of 5.9%”
The Global Intraosseous Infusion Devices Market size is expected to reach $1.4 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period.
Healthcare systems in Europe prioritize patient safety, quality of care, and technological innovation. Thus, there is growing recognition of the importance of intraosseous access as a critical tool for rapid vascular access in emergency and critical care settings. Consequently, the Europe region would acquire nearly 30% of the total market share by 2031. Also, Europe boasts a well-developed healthcare infrastructure characterized by advanced medical facilities, robust regulatory frameworks, and high standards of patient care.
In moments of medical crisis, time is of the essence. These devices circumvent delays associated with conventional intravenous access, ensuring healthcare practitioners can promptly administer crucial medications and fluids to stabilize patients. Moreover, the increasing prevalence of medical emergencies underscores the importance of robust emergency response protocols. These devices play a pivotal role in these protocols, providing healthcare teams with a versatile and effective means of vascular access in diverse clinical settings, including pre-hospital environments, emergency departments, and critical care units. Thus, these factors will assist in the growth of the market. Additionally, the utilization of these devices extends beyond traditional emergency settings, permeating critical care units, military operations, and ambulatory care settings. This diversification of usage underscores the versatility of these devices in delivering a spectrum of essential treatments, including medications, fluids, and blood products, across varied healthcare landscapes. Moreover, the rugged and unpredictable nature of military operations necessitates medical interventions that are adaptable and resilient. These devices have emerged as indispensable assets in military healthcare settings, enabling frontline medics to initiate life-saving treatments swiftly and effectively, even in austere environments or under combat conditions. Hence, these aspects will pose lucrative growth prospects for the market.
Moreover, The COVID-19 pandemic placed an unparalleled burden on healthcare systems, resulting in a surge in the need for emergency medical apparatus, such as these devices. Moreover, the pandemic prompted a shift towards pre-hospital and field medicine as healthcare systems adapt to the challenges of managing COVID-19 patients outside traditional hospital settings. These devices became essential tools for emergency medical services (EMS) personnel, military medics, and first responders providing frontline care in community settings, field hospitals, makeshift treatment centers, and mass vaccination sites, where access to advanced medical facilities may be limited. Hence, the COVID-19 pandemic positively impacted the market.
However, the initial investment required for procuring these devices can be substantial, posing a barrier to adoption for healthcare organizations operating under tight budget constraints. Furthermore, beyond initial procurement and training, ongoing maintenance and replacement of consumables constitute recurring expenses associated with these devices. Hence, these aspects can lead to a downturn in the market.
On the basis of end-use, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. In 2023, the ambulatory surgical centers segment witnessed a 28% revenue share in the market. Ambulatory surgical centers have emerged as popular alternatives to traditional hospital-based care for various surgical procedures, including minor surgeries, diagnostic and therapeutic interventions, and emergency procedures. The convenience, efficiency, and cost-effectiveness of ASCs make them attractive options for patients seeking same-day procedures or short-stay surgical care.
Based on devices type, the market is segmented into manual IO needles, battery powered driver, and impact driven devices. In 2023, the battery powered driver segment garnered a 26% revenue share in the market. Battery-powered drivers represent a significant advancement in intraosseous infusion technology, offering automated and motorized mechanisms for rapid and controlled insertion of intraosseous needles into the bone marrow space. These devices utilize battery-powered motors and mechanisms to drive the needle into the bone with consistent force and precision, minimizing user variability and enhancing procedural efficiency.
Free Valuable Insights: Global Intraosseous Infusion Devices Market size to reach USD 1.4 Billion by 2031
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 40% revenue share in the market in 2023. North America, particularly the United States, faces a high burden of traumatic injuries, emergencies, and acute medical conditions, driving the demand for rapid and reliable vascular access solutions. These devices offer a valuable alternative for obtaining vascular access in critically ill or injured patients when traditional venous access is challenging or unattainable.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 906.7 Million |
| Market size forecast in 2031 | USD 1.4 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 5.9% from 2024 to 2031 |
| Number of Pages | 164 |
| Number of Tables | 259 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Devices Type, End User, Region |
| Country scope |
|
| Companies Included | Aero Healthcare AU Pty Ltd, Teleflex Incorporated, Becton, Dickinson and Company, BIOPSYBELL S.R.L., Cook Medical, Inc.(Cook Group), The Seaberg Company Inc. (SAM Medical), Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED), Medax Srl and PAVmed Inc. |
By Devices Type
By End User
By Geography
This Market size is expected to reach $1.4 billion by 2031.
Increasing incidence of medical emergencies and trauma cases are driving the Market in coming years, however, Cost constraints and budgetary pressures in healthcare facilities challenges restraints the growth of the Market.
Aero Healthcare AU Pty Ltd, Teleflex Incorporated, Becton, Dickinson and Company, BIOPSYBELL S.R.L., Cook Medical, Inc.(Cook Group), The Seaberg Company Inc. (SAM Medical), Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED), Medax Srl and PAVmed Inc.
The expected CAGR of this Market is 5.9% from 2024 to 2031.
The Manual IO Needles segment led the Market by Devices Type in 2023; thereby, achieving a market value of $719.5 Million by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $555.1 Million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 